SEP 8, 2026 · JOURNAL ARTICLE
Prognostic Value of the Lung Immune Prognostic Index in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab: A Real-World Analysis Beyond PD-L1 Expression
Diagnostics
Real-world retrospective single-center analysis showing LIPI independently predicts survival in nivolumab-treated advanced NSCLC with statistically significant stratification and improved model discrimination, but limited by retrospective design, single center, and lack of external validation.